Skip to content

    Summit Therapeutics Inc.

    View SMMT earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance

    No price data available

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $0
    Operating Profit
    -$58.38M
    -$65.61M
    Net Profit
    -$56.25M
    -$61.20M
    -$62.91M
    -$565.71M
    -$231.79M
    -312.0%
    -$219.17M
    -258.1%
    -$189.42M
    -201.1%
    -$215.70M
    +61.9%
    Weakening
    EPS
    $-0.08
    $-0.09
    $-0.76
    $-0.31
    -287.5%
    $-0.24
    -166.7%
    $-0.28
    +63.2%
    Weakening
    Other Income
    $4.58M
    $4.42M
    $3.94M
    $2.73M
    $2.42M
    -47.2%
    $5.75M
    +30.2%
    $5.79M
    +47.0%
    $4.80M
    +75.7%
    Strengthening
    Interest
    $2.45M
    $9.0K
    $0
    $0
    $0
    -100.0%
    $0
    -100.0%
    Weakening
    Depreciation
    Profit before Tax
    MarginsOPM
    Tax
    ReturnsROIC
    2.1%
    2.3%
    2.3%
    21.0%
    8.6%
    +312.0%
    8.1%
    +258.1%
    7.0%
    +201.1%
    8.0%
    -61.9%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY19FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$35.24M$63.84M$66.42M$71.79M$348.61M$71.42M$104.86M$225.27M$419.37M
    Short-Term Investments
    Total Current Assets$79.63M$87.67M$97.31M$656.71M$189.71M$423.75M$720.30M$720.58M
    Net PP&E$1.54M$1.28M$3.48M$5.08M$6.06M$7.40M$21.68M$21.19M
    Goodwill$1.95M$1.96M$2.03M$2.01M$1.80M$1.89M$1.86M$2.00M$1.97M
    Intangibles$13.12M$11.52M$10.40M$0$0$0
    Total Assets$96.25M$102.50M$113.37M$664.17M$202.95M$435.56M$751.18M$752.18M
    LiabilitiesTotal Current Liabilities$13.77M$19.89M$25.62M$38.78M$20.41M$41.73M$72.99M$103.57M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$422.0K$75.0K$1.69M$2.76M$3.29M$3.45M$17.50M$16.83M
    Total Liabilities$17.39M$23.05M$30.09M$537.51M$125.26M$46.81M$92.32M$122.20M
    EquityCommon Stock & APIC$672.0K$826.0K$980.0K$2.11M$7.02M$7.38M$7.75M$7.93M
    Retained Earnings-$158.25M-$210.95M-$299.55M-$378.33M-$993.26M-$1.21B-$2.29B-$2.70B
    Total Equity$57.59M$78.86M$79.45M$83.28M$126.65M$77.69M$388.75M$658.86M$629.98M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY19FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$35.11M-$20.76M-$48.11M-$72.59M-$41.58M-$76.76M-$142.11M-$322.93M-$458.43M
    Cash from Investing-$331.0K-$341.0K-$421.0K-$306.0K-$624.0K-$587.77M-$205.34M-$174.31M-$262.57M
    Cash from Financing$44.51M$49.51M$50.55M$77.92M$620.24M$86.51M$381.23M$617.53M$842.51M
    SummaryCapital Expenditure-$157.0K-$205.0K-$421.0K-$306.0K-$624.0K-$128.0K-$139.0K-$657.0K-$1.39M
    Free Cash Flow-$35.26M-$20.96M-$48.53M-$72.89M-$42.21M-$76.89M-$142.25M-$323.59M-$459.82M
    FCF Margin-61.8%-2821.3%-5643.3%-4029.5%-5986.7%